KP Tissue Inc. (TSX:KPT)
Canada · Delayed Price · Currency is CAD | Market Cap | 114.25M +42.4% |
| Revenue (ttm) | n/a |
| Net Income | 8.50M +249.5% |
| EPS | 0.85 +248.6% |
| Shares Out | 10.02M |
| PE Ratio | 13.41 |
| Forward PE | 15.08 |
| Dividend | 0.72 (6.32%) |
| Ex-Dividend Date | Mar 31, 2026 |
| Volume | 14,845 |
| Average Volume | 11,324 |
| Open | 11.43 |
| Previous Close | 11.40 |
| Day's Range | 11.36 - 11.54 |
| 52-Week Range | 8.38 - 11.60 |
| Beta | 0.40 |
| RSI | 63.09 |
| Earnings Date | May 15, 2026 |
About KP Tissue
KP Tissue Inc., through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through the Consumer and Away-From-Home segments. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under Cashmere, Purex, Scotties, SpongeTowels, Bonterra and White Cloud. brand names, as well as under private labels. It sells its products through the retail channels, such as grocery stores, mass mercha... [Read more]
Financial Performance
Financial StatementsNews
KP Tissue to Release its Financial Results and Those of Kruger Products Inc. For the First Quarter of 2026
Mississauga, Ontario--(Newsfile Corp. - April 14, 2026) - KP Tissue Inc. (TSX: KPT) (KPT), which holds an interest in Kruger Products Inc. (Kruger Products), will release the financial results for KPT...
KP Tissue Earnings Call Transcript: Q4 2025
Q4 2025 saw strong revenue and margin growth, with Adjusted EBITDA up 26% year-over-year and net income turning positive. Market share gains, operational improvements, and strategic investments position the business for continued growth in 2026.
KP Tissue reports Q4 EPS C$0.26 vs. (C$0.20) last year
Reports Q4 revenue C$560.1M vs. C$539.6M last year. “Fiscal 2025 proved to be a strong year across many areas of our business, marked by share gains and revenue growth, higher
KP Tissue sees Q1 adjusted EBITDA in the range of 4Q25
The company said, “For the first quarter of 2026, we expect Adjusted EBITDA to be in the range of Q4 2025.”
KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
NOT FOR DISTRIBUTION IN THE U.S.A. OR OVER U.S. WIRE SERVICES MISSISSAUGA, Ontario, Feb. 18, 2026 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that the Board of Directors has de...
REPEAT - KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Fourth Quarter of 2025
MISSISSAUGA, Ontario, Feb. 17, 2026 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX:KPT), which holds an interest in Kruger Products Inc. (Kruger Products), will release the financial results for KPT an...
Kruger Products Closes Senior Unsecured Notes Financing
MISSISSAUGA, Ontario, Dec. 10, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that Kruger Products Inc. (“KPI”) has closed its previously announced offering of senior unsecur...
Kruger Products Prices Senior Unsecured Notes
MISSISSAUGA, Ontario, Dec. 03, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that Kruger Products Inc. (“KPI”) has, pursuant to an underwriting agreement entered into today,...
Kruger Products Announces Proposed Senior Unsecured Notes Financing
MISSISSAUGA, Ontario, Nov. 26, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that Kruger Products Inc. (“KPI”) intends, subject to market and other conditions, to offer CDN ...
KP Tissue Earnings Call Transcript: Q3 2025
Q3 2025 saw robust revenue and EBITDA growth, driven by strong consumer and away-from-home performance, premium product expansion, and operational improvements. The balance sheet was further deleveraged, and a new U.S. tissue plant was announced to support future growth.
KP Tissue Releases Third Quarter 2025 Financial Results
Accelerating profitable growth and building a new TAD tissue facility to start-up in 2028 Accelerating profitable growth and building a new TAD tissue facility to start-up in 2028
KP Tissue to Release Its Financial Results and those of Kruger Products Inc. for the Third Quarter of 2025
MISSISSAUGA, Ontario, Oct. 09, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX:KPT), which holds an interest in Kruger Products Inc. (Kruger Products), will release the financial results for KPT an...
KP Tissue Earnings Call Transcript: Q2 2025
Adjusted EBITDA rose 11% year-over-year to $72.5 million on 5% revenue growth, with strong consumer segment gains and U.S. expansion offsetting softer away-from-home sales. Q3 2025 EBITDA is guided to $75–$80 million, supported by efficiency investments and margin management.
REPEAT: KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Second Quarter of 2025
MISSISSAUGA, Ontario, Aug. 12, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX:KPT), which holds an interest in Kruger Products Inc., will release the financial results for KPT and Kruger Products ...
KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Second Quarter of 2025
MISSISSAUGA, Ontario, July 14, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX:KPT), which holds an interest in Kruger Products Inc., will release the financial results for KPT and Kruger Products ...
KP Tissue Inc. Reports on Shareholders' Voting Results for the Election of Directors
NOT FOR DISTRIBUTION IN THE U.S.A. OR OVER U.S. WIRE SERVICES MISSISSAUGA, Ontario, June 23, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) held its Annual Meeting of shareholders today.
KP Tissue Transcript: AGM 2025
The AGM highlighted record revenue and EBITDA growth in 2024, strong Q1 2025 results, and successful expansion of the Sherbrooke plant. Directors and auditors were re-elected with overwhelming support, and strategic focus remains on sustainability, brand growth, and managing tariff risks.
KP Tissue Announces Its Annual Meeting of Shareholders
MISSISSAUGA, Ontario, June 16, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) will hold its Annual Meeting of Shareholders (the Meeting) on June 23, 2025 at 2:00 p.m. (Eastern Time). The Mee...
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend KP Tissue Inc. Shareholders Vote for All Resolutions at the Upcoming Annual Meeting of Shareholders
MISSISSAUGA, Ontario, June 04, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (“KPT” or the “Company”) (TSX:KPT) is pleased to announce that both Institutional Shareholder Services (“ISS”) and Glass Lewis & ...
KP Tissue Announces Filing and Mailing of the Management Proxy Materials in Connection with its 2025 Annual Meeting of Shareholders
MISSISSAUGA, Ontario, May 20, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT or the Company) (TSX:KPT) is pleased to announce its notice of annual meeting of shareholders and management information circ...
KP Tissue Earnings Call Transcript: Q1 2025
Q1 2025 saw double-digit revenue and EBITDA growth, driven by strong sales in both Canada and the U.S., improved pricing, and operational efficiencies. The Sherbrooke expansion is on track to boost margins, while contingency plans address trade and supply risks.
KP Tissue Releases First Quarter 2025 Financial Results
MISSISSAUGA, Ontario, May 14, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) reports the Q1 2025 financial and operational results of KPT and Kruger Products Inc. (Kruger Products). Kruger P...
KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the First Quarter of 2025
MISSISSAUGA, Ontario, May 13, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (“KPT”) (TSX:KPT), which holds an interest in Kruger Products Inc., will release the financial results for KPT and Kruger Products...
KP Tissue Earnings Call Transcript: Q4 2024
Record 2024 revenue and adjusted EBITDA were achieved, with Q4 revenue up 11.9% year-over-year. About one-third of revenue faces U.S. tariff risk, but mitigation plans and strong liquidity support ongoing growth. Net loss in Q4 was driven by FX losses and higher expenses.
KP Tissue Releases Fourth Quarter and Full Year 2024 Financial Results
Record revenue surpasses $2-billion mark in 2024 combined with strong Adjusted EBITDA in all four quarters MISSISSAUGA, Ontario, March 05, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) repo...